These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 19767394)

  • 1. Mechanism for endogenously expressed ApoE modulation of adipocyte very low density lipoprotein metabolism: role in endocytic and lipase-mediated metabolic pathways.
    Huang ZH; Minshall RD; Mazzone T
    J Biol Chem; 2009 Nov; 284(46):31512-22. PubMed ID: 19767394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of adipocyte-derived apoE in modulating adipocyte size, lipid metabolism, and gene expression in vivo.
    Huang ZH; Gu D; Mazzone T
    Am J Physiol Endocrinol Metab; 2009 May; 296(5):E1110-9. PubMed ID: 19223650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperglycemia and advanced glycosylation end products suppress adipocyte apoE expression: implications for adipocyte triglyceride metabolism.
    Espiritu DJ; Huang ZH; Zhao Y; Mazzone T
    Am J Physiol Endocrinol Metab; 2010 Oct; 299(4):E615-23. PubMed ID: 20647555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein lipase- and hepatic triglyceride lipase- promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism.
    Medh JD; Fry GL; Bowen SL; Ruben S; Wong H; Chappell DA
    J Lipid Res; 2000 Nov; 41(11):1858-71. PubMed ID: 11060356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase.
    Takahashi S; Suzuki J; Kohno M; Oida K; Tamai T; Miyabo S; Yamamoto T; Nakai T
    J Biol Chem; 1995 Jun; 270(26):15747-54. PubMed ID: 7797576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue depot-specific differences in adipocyte apolipoprotein E expression.
    Huang ZH; Espiritu DJ; Uy A; Holterman AX; Vitello J; Mazzone T
    Metabolism; 2011 Dec; 60(12):1692-701. PubMed ID: 21664633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that cholesteryl ester and triglyceride accumulation in J774 macrophages induced by very low density lipoprotein subfractions occurs by different mechanisms.
    Evans AJ; Sawyez CG; Wolfe BM; Connelly PW; Maguire GF; Huff MW
    J Lipid Res; 1993 May; 34(5):703-17. PubMed ID: 8509711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of type III VLDL, their remnants, and VLDL from ApoE-knockout mice by p-hydroxyphenylacetaldehyde, a product of myeloperoxidase activity, causes marked cholesteryl ester accumulation in macrophages.
    Whitman SC; Hazen SL; Miller DB; Hegele RA; Heinecke JW; Huff MW
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1238-49. PubMed ID: 10323775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous ApoE expression modulates adipocyte triglyceride content and turnover.
    Huang ZH; Reardon CA; Mazzone T
    Diabetes; 2006 Dec; 55(12):3394-402. PubMed ID: 17130485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E2 reduces the low density lipoprotein level in transgenic mice by impairing lipoprotein lipase-mediated lipolysis of triglyceride-rich lipoproteins.
    Huang Y; Liu XQ; Rall SC; Mahley RW
    J Biol Chem; 1998 Jul; 273(28):17483-90. PubMed ID: 9651338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of chylomicron and VLDL remnants to post-heparin lipolysis in ApoE-deficient mice: the role of apoE in lipoprotein lipase-mediated lipolysis in vivo and in vitro.
    Zsigmond E; Fuke Y; Li L; Kobayashi K; Chan L
    J Lipid Res; 1998 Sep; 39(9):1852-61. PubMed ID: 9741698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein lipase binds to low density lipoprotein receptors and induces receptor-mediated catabolism of very low density lipoproteins in vitro.
    Medh JD; Bowen SL; Fry GL; Ruben S; Andracki M; Inoue I; Lalouel JM; Strickland DK; Chappell DA
    J Biol Chem; 1996 Jul; 271(29):17073-80. PubMed ID: 8663292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lipoprotein lipase induced cholesterol ester accumulation in human hepatoma HepG2 cells.
    Cianflone K; Avramoglu RK; Sawyez C; Huff MW
    Atherosclerosis; 1996 Feb; 120(1-2):101-14. PubMed ID: 8645351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipolysis is a prerequisite for lipid accumulation in HepG2 cells induced by large hypertriglyceridemic very low density lipoproteins.
    Evans AJ; Sawyez CG; Wolfe BM; Huff MW
    J Biol Chem; 1992 May; 267(15):10743-51. PubMed ID: 1587849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancer of zeste homolog 2 (EZH2) regulates adipocyte lipid metabolism independent of adipogenic differentiation: Role of apolipoprotein E.
    Yiew NKH; Greenway C; Zarzour A; Ahmadieh S; Goo B; Kim D; Benson TW; Ogbi M; Tang YL; Chen W; Stepp D; Patel V; Hilton R; Lu XY; Hui DY; Kim HW; Weintraub NL
    J Biol Chem; 2019 May; 294(21):8577-8591. PubMed ID: 30971429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very-low-density lipoprotein-induced triglyceride accumulation in human mesangial cells is mainly mediated by lipoprotein lipase.
    Li J; Li H; Wen YB; Li XW
    Nephron Physiol; 2008; 110(1):p1-10. PubMed ID: 18698144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uptake by J774 macrophages of very-low-density lipoproteins isolated from apoE-deficient mice is mediated by a distinct receptor and stimulated by lipoprotein lipase.
    Hendriks WL; van der Sman-de Beer F; van Vlijmen BJ; van Vark LC; Hofker MH; Havekes LM
    Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):498-504. PubMed ID: 9102168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia.
    Huang Y; Liu XQ; Rall SC; Taylor JM; von Eckardstein A; Assmann G; Mahley RW
    J Biol Chem; 1998 Oct; 273(41):26388-93. PubMed ID: 9756870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver.
    Mensenkamp AR; Jong MC; van Goor H; van Luyn MJ; Bloks V; Havinga R; Voshol PJ; Hofker MH; van Dijk KW; Havekes LM; Kuipers F
    J Biol Chem; 1999 Dec; 274(50):35711-8. PubMed ID: 10585451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.